Clinico-biological features and clonal hematopoiesis in patients with severe covid-19 - Université de Lille Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2020

Clinico-biological features and clonal hematopoiesis in patients with severe covid-19

Julien Goutay
  • Fonction : Auteur
Morgan Caplan
  • Fonction : Auteur
Sandrine Geffroy
  • Fonction : Auteur
Maxime Bucci
  • Fonction : Auteur
Kazali Alidjinou
  • Fonction : Auteur
Julien Poissy
  • Fonction : Auteur


Advanced age or preexisting comorbidities have been characterized as risk factors for severe coronavirus disease 2019 (COVID-19) cases requiring hospitalization and intensive care. In recent years, clonal hematopoiesis (CH) of indeterminate potential (CHIP) has emerged as a risk factor for chronic inflammatory background and subsequent aging-associated diseases. The purpose of this study was to identify biological factors (particularly leukocyte subtypes and inflammatory markers) associated with a risk of clinical deterioration (i.e., orotracheal intubation (OTI)) and to determine whether CH was likely to influence clinical and biological behavior in patients with severe COVID-19 requiring hospitalization. Here, we describe clinical and biological features, including the screening of CHIP mutants in a well-annotated cohort of 122 hospitalized patients with a laboratory-confirmed diagnosis of COVID-19 (55% requiring OTI). We showed that elevated white blood cell counts, especially neutrophils and high C-reactive protein (CRP) levels at admission, were associated with an increased requirement of OTI. We noticed a high prevalence of CH (25%, 38%, 56%, and 82% of patients aged <60 years, 60-70 years, 70-80 years, and >80 years) compared to a retrospective cohort of patients free of hematological malignancy explored with the same pipelines (10%, 21%, 37%, and 44%). However, the existence of CH did not significantly impact clinical outcome, including OTI or death, and did not correlate with other laboratory findings.
Fichier principal
Vignette du fichier
cancers-12-01992-v2.pdf (2.4 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03854877 , version 1 (16-11-2022)





Nicolas Duployez, Jordane Demonchy, Celine Berthon, Julien Goutay, Morgan Caplan, et al.. Clinico-biological features and clonal hematopoiesis in patients with severe covid-19. Cancers, 2020, Cancers, 12 (7), pp.1992. ⟨10.3390/cancers12071992⟩. ⟨hal-03854877⟩
19 Consultations
7 Téléchargements



Gmail Facebook X LinkedIn More